Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion type Assertion NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_head.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion wasGeneratedBy ECO_0000203 NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_provenance.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion wasDerivedFrom befree-2016 NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_provenance.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion SIO_000772 24685829 NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_provenance.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion evidence source_evidence_literature NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_provenance.
- NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_assertion description "[Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168973.RASvGU1F8wwLe8R-Rj3sD0ffaPdc2DiTfFkKhfjYaPsdU130_provenance.